FDA issues warning against tianeptine use, also called 'gas station heroin'
This article discusses suicidal ideation. If you or someone you know is struggling or in crisis, help is available. Call or text 988 or chat at 988lifeline.org.
The U.S. Food and Drug Administration is warning the public about a drug rising in popularity, commonly referred to as "gas station heroin."
Tianeptine poses a "dangerous and growing health trend" across the U.S., particularly putting young people at risk, Food and Drugs Commissioner Dr. Marty Makary said in a May 8 news release.
No use of the drug has received FDA approval as it can result in serious harm or death, Makary clarified. He emphasized the public must address the trend before it becomes the latest example of delayed recognition patterns previously seen in opioid abuse and youth vaping.
"I am very concerned. I want the public to be especially aware of this dangerous product and the serious and continuing risk it poses to America's youth," Makary said. "While the FDA is closely following the distribution and sale of these products, it is critical that you appreciate the magnitude of the underlying danger of these products, and disseminate information about it."
Here's what to know about tianeptine.
Tianeptine has been banned in 10 U.S. states:
Alabama
Florida
Georgia
Indiana
Kentucky
Michigan
Mississippi
Ohio
Tennessee
North Carolina
Makary said tianeptine is sold under various product names, including Tianaa, Zaza, Neptune's Fix, Pegasus and TD Red.
Tianeptine is licensed in some countries and marketed as an atypical antidepressant meant to treat depression through three daily 12.5 mg oral doses, according to Makary.
"Higher doses can produce euphoria, and some countries have restricted how tianeptine is prescribed and dispensed or revised the drug label to warn of possible addiction," Makary said. "FDA recommends that health care professionals encourage patients to avoid all products containing tianeptine, including those claiming to treat an ailment or disorder."
Tianeptine is prescribed as an antidepressant in some European, Asian and Latin American countries, but it's not approved for any medical use in the U.S.
Still, companies are marketing and selling tianeptine products as dietary supplements typically in pill and powder form, claiming it can improve brain function and treat depression, anxiety, pain and even opioid use disorder.
The drug is typically available gas stations, convenience stores, vape shops and online retailers, according to the FDA.
While many use tianeptine to treat their ailments and assume they are safe because of their availability. However, the FDA said tianeptine is a prime example of availability not indicating effectiveness or safety.
Tianeptine has been banned in Alabama, Florida, Georgia, Indiana, Kentucky, Michigan, Mississippi, Ohio and Tennessee.
According to the Cleveland Clinic, tianeptine is addictive.
In an April 2024 interview with USA TODAY, Alabama woman Chrissy Reifschneider said she tried tianeptine pills after a family member who worked at a gas station recommended them to her. Within days, she said she became addicted to the drug, and experienced three gruesome years.
Reifschneider said she took about five pills every four hours in which she experienced hair loss, weight loss, auditory hallucinations; developed paranoia surrounding electronics and suicidal ideations.
"I thought well, I'm not sticking a needle in my arm, so I literally convinced myself that I wasn't a drug addict until I realized I didn't recognize who I was anymore," Reifschneider, who is now sober, told USA TODAY last year. "It's crazy to think that these gas station pills just controlled me. I was ashamed because I'd rather people know I was shooting up heroin than actually spending all this time and money on over-the-counter (drugs)."
The FDA lists the following adverse events reported in people who ingested tianeptine.
Agitation
Confusion
Drowsiness
Nausea
Sweating
Vomiting
Tachycardia
Hypertension
Respiratory depression
Coma
Death
The FDA also said some symptoms of tianeptine withdrawal are similar to opioid discontinuation, including:
Craving
Sweating
Goose flesh or goosebumps
Diarrhea
Muscle aches and pain
Contributing: Katie Camero
This article originally appeared on USA TODAY: Gas station heroin: FDA warns public of tianeptine use
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News24
an hour ago
- News24
Joburg woman finishes epic N1 walk to Cape Town for husband's rare disease 10 days early
Nicole Liedemann-Telukram completed her 1 400km walk from Johannesburg to Cape Town 10 days ahead of schedule, raising awareness and funds for her husband Shaun's rare condition, Dercum's disease. Supported throughout the journey by her best friend, Paballo, in a safety vehicle and her trusty boerboel, Zaza, Nicole described the journey as physically and emotionally transformative, highlighting the mental endurance required and the generosity of South Africans along the way. The campaign has raised R15 000 so far, and Nicole remains committed to fighting for rare disease research and funding, saying, 'This is just the start.' Nicole Liedemann-Telukram has completed her 1 400km walk from Johannesburg to Cape Town, 10 days ahead of schedule. Just over a month ago, Nicole decided to embark on a journey along the N1 to raise awareness and funds for her husband Shaun Telukram's rare disease, called Dercum's disease. She documented the trip on TikTok and directed followers to her fundraising platforms. - See Nicole's BackaBuddy page More than a month after starting the walk, she arrived in sunny Cape Town to take a photo at the famous V&A Waterfront sign. Her journey was not without difficulties. A pulled hamstring just after Lainsburg and the physical demands of walking the Huguenot Tunnel tested her endurance. One of the most physically taxing parts of her journey was near Colesberg when she battled blisters and the flu. 'My body felt like it was giving up on me,' Nicole told News24 in Cape Town. 'When you are walking, it's only yourself and your thoughts. I don't walk with earphones in; it's just myself and the road. Your mind gets to you, where you feel self-doubt, but you have to pull yourself towards yourself and remind yourself the reason why you are doing it.' While the first leg of the journey began with excitement, the second half became more difficult. 'It's not just about Dercum's, it's about so many things,' she said. Nicole expressed deep gratitude for the support of her best friend, Paballo, who accompanied her by car for the entire journey for safety and her trusty boerboel, Zaza. 'Paddy, my sister, my best friend, motivator, Swiss Army knife, master of all... I could not be more grateful. I don't think there are enough words to describe how blessed I was to have had her on this journey. Yes, I was walking, but I could not have done it without her.' Supplied/Neo Paballo-Mahao Because the pair remained vigilant, they generally felt safe on their journey. One hair-raising moment came in Paarl, where they heard that a body had been found nearby. This did not deter them: 'There was a task that needed to be completed, a personal task, a mental task, an emotional task, a physical task. And yes, we completed it. I'm still in awe.' Kind South Africans and the plight goes on Nicole arrived in Cape Town last week with a deep sense of fulfilment. 'I sat there in silence with a big smile on my face. We did it. I actually did it. When you do something out of your comfort zone and succeed, it takes you back a little. I was filled with emotion, excitement and fulfilment.' READ | Joburg woman halfway through N1 walk to Cape Town, beating blisters, blessed by strangers Messages of pride and congratulations from family and friends continue to pour in. 'I hope I reached the people I needed to. The people we spoke to along the way made it all worthwhile. Mentally, I'm okay – I haven't processed everything yet, but I'm still extremely positive and optimistic.' The campaign has so far raised around R15 000 and Nicole is determined to continue her fundraising efforts and search for sponsors, as they aim to reach R200 000. Dr Karen Herbst, one of the leading Dercum's researchers in the world, based in the US, also got in touch to amplify Nicole's efforts. 'We did not raise too much, but my plight has not stopped. I'm still continuing to raise awareness and funds. We didn't raise much at all, but it doesn't take away from the reason why I did this and why I am still going to continue to fight for a rare disease and for my husband.' Rare disease research is underfunded. We need chemical pathologists to do the work, but we also need the funding. My mission is not complete yet. Reflecting on the experience, Nicole said the journey was unforgettable. 'South Africa is a beautiful place. People in small towns are kind and generous. The trucking community became our cocoon of safety. We stayed at truck stops. There are so many people I want to thank. There are a lot of amazing people in this country.' 'This is just the start.'
Yahoo
3 hours ago
- Yahoo
Recall alert: Over 19,000 cans of Dr Pepper Zero Sugar recalled for containing sugar
Over 19,000 cases of Dr Pepper Zero Sugar are being recalled after the cans were found to contain full-sugar soda, the U.S. Food and Drug Administration announced. The voluntary recall issued on May 23 affects the 12-ounce aluminum cans of a 12-pack and 24-pack case of Dr Pepper Zero Sugar. 'Product labeled to be zero sugar contains full sugar product,' the FDA wrote about the drink. The recalled product contains the same amount of sugar found in regular Dr Pepper, which is 39 grams per can. The recalled cans have the product code XXXXRS05165 with a 'best by' date of February 16, 2026. The cans were made by Pepsi Beverages Company in Jacksonville, Florida and distributed to only Florida, Georgia and South Carolina. On June 5, the FDA then classified the product as a class II recall. This level of recall is 'a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,' according to the FDA. See the full recall here. Recall alert: These window air conditioners could cause mold exposure Recall alert: Bring these crackers back to the store due to undeclared allergen Recall alert: Throw away these 17 salads, salsas due to salmonella concern Read the original article on MassLive.
Yahoo
3 hours ago
- Yahoo
Parents are dismayed after FDA rejects experimental drug 4-year-old girl relies on
A family thought they had a life-changing drug for their 4-year-old daughter. Then the FDA rejected it. Channel 2's Michael Doudna heard from the girl's parents. For Hope Filchak, her daily routine includes a daily shot to help provide a normal life. However, soon the drug may go away. 'It's scary to think she might not have this in just a few months,' Caroline Filchak, Hope's mother, said. [DOWNLOAD: Free WSB-TV News app for alerts as news breaks] Hope was born with a rare mitochondrial disease that impacts fewer than 100 people in the world. The impacts are wide-ranging and a challenge to overcome. 'From early on, it was an uphill battle for Hope,' Caroline Filchak said. 'I think she's got 12 specialists that we see in three different states.' 'It affects her brain, her heart, her eyes and her ears, deafness, blindness, and then two heart defects,' Ben Filchak, Hope's father, said. There are no FDA-approved drugs for Hope's condition. So when heart troubles arose in 2024, the family was forced to turn to an experimental drug, elemipretide, and saw immediate improvement. 'Her energy increased, and her heart function has stabilized completely,' Ben Fiilchak said. However, last month, the FDA declined to give it approval. 'I would say that the FDA is trying to regulate two things, right. They're trying to make sure the products are safe, including drugs, but also that they are efficacious for people,' said Rossana Sanchez Russo, an Emory clinical geneticist. According to the parent company producing the drug, the FDA's rejection was in part because the FDA did not see an improvement in a six-minute walk test. 'We all know in the field that a six-minute walk test is not the be-all end-all outcome measure for mitochondrial diseases,' Amy Goldstein, a leading mitochondrial disease expert, said. She says the drug showed improvement in areas such as quality of life and cardiac health. 'I myself personally saved a baby in my cardiac ICU with Barre syndrome. He went home with no cardiac manifestations after arriving here in severe heart failure and needing a heart transplant,' Goldstein said. 'We were extremely disappointed that based on all of the data, they made the decision not to approve the drug.' Another hurdle rare disease drug testing faces is sample size. By its very nature, only a few people have these diseases, so getting a meaningful sample during clinical trials can be difficult. 'Sometimes we don't have enough burden of proof to be able to formally say that. That doesn't mean that it may not be working for a family or that it might not work for other conditions. It may mean that we just do not have all the data,' Sanchez Russo said. The FDA says the company behind the drug can reapply for approval, but it is unclear if it will be successful and how long the company can stay committed to producing a drug without the FDA giving an OK. Hope's family has a four-month supply of the drug left. However, they do not know how much longer access to the medicine will last. 'Hope is a special little girl, and she means so much to our family,' Caroline Filchak said. TRENDING STORIES: Raids uncover largest fentanyl pill operation in state history in Atlanta, Douglasville Hurricane season starts quietly in the Atlantic They were once best friends, then one killed the other. We take you inside this bizarre murder case [SIGN UP: WSB-TV Daily Headlines Newsletter]
